House of Commons
Successful result of Oxford covid-19 vaccine Phase I/II trials
EDM #746
Tabled 20 July 2020
2019-21 Session
That this House congratulates Oxford University’s Jenner Institute and the Oxford Vaccine Group for the successful completion of the Phase I/II trial of its covid-19 vaccine; notes that no early safety concerns were indicated and that strong immune responses in both parts of the immune system were induced; acknowledges that the team behind the Oxford vaccine have worked urgently since January 2020 to achieve this; thanks the scientists, trial volunteers and others involved for the service they have done for the UK and global effort to tackle covid-19; further notes that there are further stages to follow before the vaccine can be administered to the general public; and calls on the Prime Minister and the Government to ensure those leading the Oxford vaccine project receive the honours they deserve.

Signatures (5)

The first 6 Members who have signed to support the motion are the sponsors. The primary sponsor is generally the person who tabled the motion and has responsibility for it. The date shown is when the Member signed the motion.
There are no withdrawn signatures for this Motion